"The insulin pricing crisis will only be solved when everyone can access and afford insulin," said insulin4all advocate Allison Bailey. (Photo: 2C2KPhotography/flickr/cc)
May 08, 2019
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
\u201cSUCCESS! -5-hour road trip. \u2705 -Insulin purchased where NO prescription was needed! \u2705 1 vial of Novolog in the USA \ud83c\uddfa\ud83c\uddf8 = 10 vials of NovoRapid in Canada \ud83c\udde8\ud83c\udde6\u2705 =6 happy & grateful ppl w/type 1 diabetes & T1 Mom\u2019s \ud83d\ude4f\ud83c\udffb\ud83d\udc99#CaravanToCanada #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557011340
\u201cA 5 hr road trip & this is the difference in $ for the same product (they just change the name). Where have we gone wrong America?!? We should be ashamed as a country that this is a solvable issue, and nothing has been done to make it more affordable. #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557082029
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
\u201cAmericans are forming a caravan to travel to Canada to buy affordable insulin. \n\n1\ufe0f\u20e3You are very welcome.\n\n2\ufe0f\u20e3I\u2019m sorry that you need to do this.\n#CaravanToCanada #insulin4all\u201d— Chris Houston (@Chris Houston) 1557005499
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
\u201cThe insulin pricing crisis will only be solved when everyone can access and afford insulin. #insulin4all means ALL. And we will only achieve that when every patient in the U.S. can go to their local pharmacy and get the insulin they need for a reasonable price.\u201d— Allison Bailey \ud83d\udd6f\ufe0f (@Allison Bailey \ud83d\udd6f\ufe0f) 1557264033
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. The final deadline for our crucial Summer Campaign fundraising drive is just days away, and we’re falling short of our must-hit goal. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
\u201cSUCCESS! -5-hour road trip. \u2705 -Insulin purchased where NO prescription was needed! \u2705 1 vial of Novolog in the USA \ud83c\uddfa\ud83c\uddf8 = 10 vials of NovoRapid in Canada \ud83c\udde8\ud83c\udde6\u2705 =6 happy & grateful ppl w/type 1 diabetes & T1 Mom\u2019s \ud83d\ude4f\ud83c\udffb\ud83d\udc99#CaravanToCanada #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557011340
\u201cA 5 hr road trip & this is the difference in $ for the same product (they just change the name). Where have we gone wrong America?!? We should be ashamed as a country that this is a solvable issue, and nothing has been done to make it more affordable. #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557082029
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
\u201cAmericans are forming a caravan to travel to Canada to buy affordable insulin. \n\n1\ufe0f\u20e3You are very welcome.\n\n2\ufe0f\u20e3I\u2019m sorry that you need to do this.\n#CaravanToCanada #insulin4all\u201d— Chris Houston (@Chris Houston) 1557005499
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
\u201cThe insulin pricing crisis will only be solved when everyone can access and afford insulin. #insulin4all means ALL. And we will only achieve that when every patient in the U.S. can go to their local pharmacy and get the insulin they need for a reasonable price.\u201d— Allison Bailey \ud83d\udd6f\ufe0f (@Allison Bailey \ud83d\udd6f\ufe0f) 1557264033
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
\u201cSUCCESS! -5-hour road trip. \u2705 -Insulin purchased where NO prescription was needed! \u2705 1 vial of Novolog in the USA \ud83c\uddfa\ud83c\uddf8 = 10 vials of NovoRapid in Canada \ud83c\udde8\ud83c\udde6\u2705 =6 happy & grateful ppl w/type 1 diabetes & T1 Mom\u2019s \ud83d\ude4f\ud83c\udffb\ud83d\udc99#CaravanToCanada #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557011340
\u201cA 5 hr road trip & this is the difference in $ for the same product (they just change the name). Where have we gone wrong America?!? We should be ashamed as a country that this is a solvable issue, and nothing has been done to make it more affordable. #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557082029
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
\u201cAmericans are forming a caravan to travel to Canada to buy affordable insulin. \n\n1\ufe0f\u20e3You are very welcome.\n\n2\ufe0f\u20e3I\u2019m sorry that you need to do this.\n#CaravanToCanada #insulin4all\u201d— Chris Houston (@Chris Houston) 1557005499
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
\u201cThe insulin pricing crisis will only be solved when everyone can access and afford insulin. #insulin4all means ALL. And we will only achieve that when every patient in the U.S. can go to their local pharmacy and get the insulin they need for a reasonable price.\u201d— Allison Bailey \ud83d\udd6f\ufe0f (@Allison Bailey \ud83d\udd6f\ufe0f) 1557264033
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.